Background: Dengue is a vector borne viral disease. Female Anopheles mosquito is the vector for the disease. There is increased incidence of dengue infection in the adult population of South Asian countries. The outcome of dengue in pregnancy is similar to that in non pregnant woman. There is increased incidence of abortions, preterm births, IUGR babies, and bleeding manifestations like PPH, epistaxis. Timely intervention can improve the maternal and fetal outcome. This study aims to study the maternal and fetal outcome of dengue during
pregnancy. Methods: Pregnant women, admitted with fever during the seasonal outbreak of dengue, between August 2018 to October 2018 were studied in the department of Obstetrics & Gynecology, SHKBM, Jhalawar, Rajasthan. Serological testing for dengue virus specific antigen and antibody was done for the diagnosis of dengue fever. The World Health Organization (WHO) classification and case definitions 2009 were used to categorize the dengue patients. Maternal surveillance and fetal surveillance was done. Data was collected related to maternal and fetal consequence both during pregnancy and birth, as well as the effect on newborn. Informed and written consent was taken from all those who participated in the study. Results: The mean age at admission was 22 years. Thrombocytopenia (<50,000/cu mm) in 4 women (7.84%). Blood product transfusion was required in 5 (9.8%) of women. 23 (45.09%) had oligohydramnios, 27 (52.94%) had bleeding manifestations, 7 (13.72%) were admitted in the ICU. Adverse fetal outcome was seen as, 9 (17.64%) babies were premature, 17 (21.56%)
were admitted in NICU, and 1 (1.9%) had IUD. Conclusion: Dengue fever is associated with increased materno fetal morbidity and mortality.
Early detection and treatment are the mainstay to improve the prognosis of this viral infection.